Objectives: The aim of this study was to investigate the ocular surface, intraocular pressure,
and lens condition in bronchodilator-and steroid-treated chronic pulmonary disease …

Background and objective: The risk of cataracts associated with the long‐term use of inhaled
corticosteroids (ICS) is poorly recognized, yet may be of major public health importance. The …

Orally inhaled corticosteroid use has been convincingly linked to an increase in the risk of
cataracts, although the risk at lower doses in common use remains uncertain. The potential …

Purpose: Exposure to corticosteroids is known to be associated with an increased risk of
cataract and glaucoma. This study was undertaken to determine the prevalence of steroid …

Purpose. Both systemic and inhaled corticosteroids may increase the risk of cataract in
patients with both chronic obstructive pulmonary disease (COPD) and asthma. Our aim was …

Prolonged exposure to inhaled corticosteroids among adults over 49 years old has been
reported to increase cataract risk. Small-scale studies of inhaled steroid users suggest that …

Background/aims: Exposure to systemic corticosteroid use is known to be associated with a
risk of cataract. Whether low doses of inhaled corticosteroids are associated with an …

Objectives Some large population-based studies have reported a dose-related increased
risk of cataracts and glaucoma associated with use of inhaled corticosteroids (ICS) in …

The objective of this study was to quantify the risk of cataract among users of inhaled
corticosteroids (ICS). Studies that examined the association of ICS use with risk of cataract …

Oral and topical (ocular) corticosteroids are known to have the potential to cause cataracts,
but inhaled corticosteroids have generally been considered to be free of this adverse effect …